drugset / Trial / NCT00374192
The Treatment of Insomnia in Symptomatic Peri- and Postmenopausal Women
RandomizedCrossoverTriple-blindTreatment
Summary
To examine the change in sleep patterns and mood symptoms in response to eszopiclone (Lunesta) using a double-blind placebo-controlled cross-over study design in perimenopausal and postmenopausal women who experience insomnia, mild depression and/or anxiety.
Timeline
- Start
- 2006-02
- Primary completion
- 2007-07
- Completion
- 2007-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Eszopiclone | Small molecule | 3 mg | — |